Systemic Janus kinase inhibitor treatment for vitiligo: An evidence-based review

Affiliations

• ¹ Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
• ² Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
• ³ Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Department of Dermatology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
• ⁴ Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada; Dermatology Research Institute, Calgary, Alberta, Canada; Skin Health & Wellness Centre, Calgary, Alberta, Canada; Section of Community Pediatrics, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada; Section of Pediatric Rheumatology, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada; Probity Medical Research, Waterloo, Ontario, Canada.
• ⁵ Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Department of Dermatology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; Probity Medical Research, Waterloo, Ontario, Canada; Department of Dermatology, Women's College Hospital, Toronto, Ontario, Canada. Electronic address: [email protected].